Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up
AV

AVNS

Market Closed

Avanos Medical, Inc.

NYSEHealthcareMedical - Devices
US
2.29K employees
CEO: David C. Pacitti
Founded: 2014
$24.99
+$0.00(+NaN%)
Market Cap
1.17B
Beta
1.57
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Avanos Medical trades 47% above its high-confidence fair value estimate of $13.18, indicating potential overvaluation despite no downside risk in Monte Carlo scenarios. DCF suggests deep undervaluation (-$17.01 mid), but price/sales and analyst targets imply a mixed outlook. Financials reveal strong liquidity and leverage, but zero profitability and efficiency raise risk concerns.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore AVNS

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

AVNS in the Healthcare

Small Cap
Healthcare

Browse sector stocks →

Medical - Devices

Browse industry stocks →

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms